SEC 13F Intelligence

Ayrton Capital LLC / PMCB

Ayrton Capital LLC’s Pharmacyte Biotech Inc Position

Does Ayrton Capital LLC own Pharmacyte Biotech Inc (PMCB)? Yes — 92.1K shares worth $193,383 (+1.31% of its 13F portfolio) as of Q3 2023, down from 277.0K shares the prior filed quarter.

Position Value
$193,383
Q3 2023
Shares
92.1K
% of Portfolio
+1.31%
Quarters Held
8
currently held

Position History PMCB

Reported value by quarter
Q4 ’21: $383,000Q4 ’21Q1 ’22: $352,000Q1 ’22Q2 ’22: $343,000Q2 ’22Q3 ’22: $2MQ3 ’22Q4 ’22: $3MQ4 ’22Q1 ’23: $3MQ1 ’23Q2 ’23: $792,197Q2 ’23Q3 ’23: $193,383Q3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202392.1K$193,383+1.31%
Q2 2023277.0K$792,197+4.95%
Q1 20231.03M$3M+10.77%
Q4 20221.03M$3M+8.27%
Q3 20221.03M$2M+4.35%
Q2 2022153.1K$343,000+0.56%
Q1 2022153.1K$352,000+0.46%
Q4 2021153.1K$383,000+0.36%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ayrton Capital LLC’s full portfolio or all institutional holders of PMCB.